These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification. Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165 [TBL] [Abstract][Full Text] [Related]
5. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434 [TBL] [Abstract][Full Text] [Related]
6. Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury. Tsuji H; Wang W; Sunil J; Shimizu N; Yoshimura K; Uemura H; Peck AB; Khan SR World J Urol; 2016 Jan; 34(1):89-95. PubMed ID: 25981400 [TBL] [Abstract][Full Text] [Related]
7. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458 [TBL] [Abstract][Full Text] [Related]
8. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1. Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331 [TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism. Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962 [TBL] [Abstract][Full Text] [Related]
10. Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease. Naito Y; Fujii A; Sawada H; Hirotani S; Iwasaku T; Eguchi A; Ohyanagi M; Tsujino T; Masuyama T J Hypertens; 2012 Nov; 30(11):2192-201. PubMed ID: 22922699 [TBL] [Abstract][Full Text] [Related]
11. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. Nagase M; Yoshida S; Shibata S; Nagase T; Gotoda T; Ando K; Fujita T J Am Soc Nephrol; 2006 Dec; 17(12):3438-46. PubMed ID: 17082236 [TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996 [TBL] [Abstract][Full Text] [Related]
14. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts. Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451 [TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat. Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739 [TBL] [Abstract][Full Text] [Related]
16. Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis. Baudrand R; Gupta N; Garza AE; Vaidya A; Leopold JA; Hopkins PN; Jeunemaitre X; Ferri C; Romero JR; Williams J; Loscalzo J; Adler GK; Williams GH; Pojoga LH J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27680666 [TBL] [Abstract][Full Text] [Related]
17. The Inhibitory Effect of Eplerenone on Cell Proliferation in the Contralateral Kidneys of Rats with Unilateral Ureteral Obstruction. Wang CH; Wang Z; Liang LJ; Wang XT; Ma XL; Liu BB; He JQ; Shimosawa T; Xu QY Nephron; 2017; 136(4):328-338. PubMed ID: 28402979 [TBL] [Abstract][Full Text] [Related]
18. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease. Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of proanthocyanidins in the cardiac alterations induced by aldosterone in rat heart through mineralocorticoid receptor blockade. Martín-Fernández B; de las Heras N; Valero-Muñoz M; Ballesteros S; Yao YZ; Stanton PG; Fuller PJ; Lahera V PLoS One; 2014; 9(10):e111104. PubMed ID: 25353961 [TBL] [Abstract][Full Text] [Related]
20. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Lastra G; Whaley-Connell A; Manrique C; Habibi J; Gutweiler AA; Appesh L; Hayden MR; Wei Y; Ferrario C; Sowers JR Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E110-6. PubMed ID: 18445755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]